AI is rewriting drug discovery. Recursion Pharmaceuticals and Tempus AI might be the platforms that turn early investors into millionaires.

Four years on from the devastating Lismore floods the disaster recovery program that followed is being wound down. Hundreds of millions of dollars have been spent on a house buyback program. And while ...

Pentagon's OPEN program to help set China-free minerals prices Four critical minerals to be AI model's first focus Program aims to help offset Chinese market interference Questions on how tariffs ...

NYU Langone’s decision comes amid Trump administration threats to cut funding to providers who treat trans youth NYU Langone Health, one of New York City’s major hospital networks, announced this week ...

Bitter cold and slick roads are left behind after lake effect snow Monday lasted through the night.Several schools were closed or delayed Tuesday due to the sno FEMA, state officials start tornado ...

Companies in the 8(a) small business contracting program are facing unprecedented pressure as the Trump administration paints it as rife with corruption and a bastion of illegal diversity, equity, and ...

The T32 grant provides full-time research training support for post-candidacy predoctoral learners pursuing mentored clinical and translational research or clinical and translational science who are ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

Luxury EVs in China now offer 24-karat gold badges and Porsche-like options — but at half the price. Porsche faces a myriad of problems in China. For one, the brand’s cars are somewhat niche by design ...

This article was updated Wednesday to include information from the Air Force Aid Society and Coast Guard Mutual Assistance. If the government shutdown that was triggered late Tuesday starts affecting ...

At-a-Glance: The strongest petroleum engineering programs cluster in North America (notably the U.S. Gulf/Permian states), the U.K./Norway, the Middle East, China/India, and select Latin American and ...

Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today announced ...